Choksi Asia Share Price & Earnings Call Analysis

Financials of Choksi Asia

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Choksi Asia

Quarterly Results

Quarter-by-quarter operating performance

Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales +0.040.280.400.523.040.151.378.428.6712.1511.9013.2912.26
Expenses +0.530.450.771.153.230.561.097.458.9510.9110.5111.6910.47
Operating Profit-0.49-0.17-0.37-0.63-0.19-0.410.280.97-0.281.241.391.601.79
OPM %-1,225.00%-60.71%-92.50%-121.15%-6.25%-273.33%20.44%11.52%-3.23%10.21%11.68%12.04%14.60%
Other Income +0.400.240.380.200.470.250.190.240.820.230.290.290.52
Interest0.000.000.000.000.000.000.000.130.120.090.100.140.09
Depreciation0.040.040.040.040.050.040.040.040.050.040.060.080.05
Profit before tax-0.130.03-0.03-0.470.23-0.200.431.040.371.341.521.672.17
Tax %-7.69%-33.33%0.00%0.00%-173.91%-255.00%16.28%36.54%40.54%47.01%28.95%19.16%1.38%
Net Profit +-0.120.04-0.03-0.470.630.310.360.650.220.711.071.352.13
EPS in Rs-0.310.10-0.08-1.211.620.790.921.670.561.821.882.373.74

Financials of Choksi Asia

Profit & Loss

Annual income statement trend

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales +170.21108.0345.9627.2623.0817.3316.0011.162.460.7715.9936.9849.60
Expenses +172.79106.1943.4026.3121.7717.7517.4212.853.922.2116.0133.1743.58
Operating Profit-2.581.842.560.951.31-0.42-1.42-1.69-1.46-1.44-0.023.816.02
OPM %-1.52%1.70%5.57%3.48%5.68%-2.42%-8.88%-15.14%-59.35%-187.01%-0.13%10.30%12.14%
Other Income +0.060.070.400.430.741.641.064.581.141.162.101.581.33
Interest3.291.560.370.000.000.000.000.000.000.000.400.480.42
Depreciation0.600.440.410.390.220.210.170.190.170.160.180.180.23
Profit before tax-6.41-0.092.180.991.831.01-0.532.70-0.49-0.441.504.736.70
Tax %0.94%-577.78%0.92%22.22%30.05%14.85%5.66%29.26%-12.24%6.82%7.33%34.25%
Net Profit +-6.460.422.170.771.290.86-0.561.91-0.42-0.481.393.105.26
EPS in Rs-16.561.085.561.973.312.21-1.444.90-1.08-1.233.567.959.81
Dividend Payout %0.00%46.43%17.97%37.99%22.67%22.67%0.00%51.05%0.00%0.00%0.00%0.00%

Financials of Choksi Asia

Balance Sheet

Capital structure and asset base

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital3.903.903.903.903.903.903.903.903.903.905.705.7011.09
Reserves8.788.3110.0110.9911.9212.4211.6213.5312.0911.6222.3725.7928.09
Borrowings +17.656.430.000.000.000.000.000.000.000.009.2110.163.04
Other Liabilities +23.6317.0922.4520.8020.8820.9120.083.792.422.534.515.524.70
Total Liabilities53.9635.7336.3635.6936.7037.2335.6021.2218.4118.0541.7947.1746.92
Fixed Assets +10.108.818.508.037.817.517.346.125.955.7914.9515.5816.24
CWIP0.000.000.000.000.000.000.000.000.000.000.000.000.00
Investments0.000.003.877.495.362.936.870.783.350.000.000.000.00
Other Assets +43.8626.9223.9920.1723.5326.7921.3914.329.1112.2626.8431.5930.68
Total Assets53.9635.7336.3635.6936.7037.2335.6021.2218.4118.0541.7947.1746.92

Financials of Choksi Asia

Cash Flows

Operating, investing and financing cash movement

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity +15.6710.647.931.655.492.42-2.52-2.82-0.56-2.522.68-2.87
Cash from Investing Activity +-0.30-0.12-0.17-0.010.000.58-0.011.96-2.493.351.520.63
Cash from Financing Activity +-15.01-11.45-6.900.00-0.35-0.35-0.240.00-0.980.000.47-1.20
Net Cash Flow0.36-0.940.861.655.142.64-2.77-0.85-4.020.834.67-3.43
Free Cash Flow15.3610.527.761.645.493.00-2.53-0.86-0.56-2.522.79-3.69
CFO/OP-608%578%308%174%422%-581%177%153%25%175%-13,400%-75%

Financials of Choksi Asia

Ratios

Working capital efficiency and return ratios

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days49.4332.7763.4578.86106.43103.41107.6832.7189.02180.1381.7282.22
Inventory Days33.9046.51101.48125.3789.13155.93112.8434.4771.321,971.00149.98106.20
Days Payable44.6053.76209.89350.06406.96502.85531.0744.8127.2787.6046.4939.44
Cash Conversion Cycle38.7325.52-44.96-145.82-211.39-243.51-310.5522.37133.082,063.53185.21148.99
Working Capital Days0.884.05-12.31-74.85-114.50-139.43-178.1777.19381.322,360.65131.25138.28
ROCE %-7.60%6.00%15.67%6.53%9.64%5.66%-3.33%16.39%-2.93%-2.79%7.20%13.20%

Others in Healthcare Equipment & Supplies this season

  • Molbio Diagnostics Ltd (Q1 FY27)

    Capacity utilization currently at ~58% for test kits and ~42% for devices; automation capex will double revenue capacity with minimal new investment. Key…

  • QMS Medical Allied Services Ltd (Q1 FY27)

    Contract renewals historically exhibit a 60-70% roll-over rate annually, ensuring revenue visibility from existing clients. Key concall takeaways from QMS…

  • Laxmi Dental Ltd (Q1 FY27)

    PAT grew 23.8% y-o-y in Q1 FY27, showing healthy bottom-line growth (Page 4). Key concall takeaways from Laxmi Dental Ltd's Q1 FY27 earnings call — and how it…

  • Tarsons Products Ltd (Q2 FY26)

    Plastic labware market is expanding faster than glass, currently at INR1,200 crores, signaling long-term sector growth opportunities. Key concall takeaways…

Compare:vs Poly Medicure Ltdvs Molbio Diagnostics Ltdvs Fischer Medical Ventures Ltd